Evaluation of Diagnostic Biomarkers


Biomarkers provide a characterized bank of immunology which diverse human peripheral blood nonnuclear cells that access the impact of drugs on immune-related protein biomarkers by using multiple readouts and technology platforms. It is also the platform for 3d polycystic kidney disease assays


  • Asses the risk of cytokine release syndrome
  • Biomarkers screening and identification
  • Assay and platform, using human taste bud epithelial cells

Related Conference of Evaluation of Diagnostic Biomarkers

November 27-28, 2024

14th World Congress on Analytical & Bioanalytical Techniques

Amsterdam, Netherlands
November 28-29, 2024

20th European Organic Chemistry Congress

Paris, France
December 12-13, 2024

23rd World Congress on Nutrition and Food Chemistry

Rome, Italy
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands
January 27-28, 2025

25th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
March 13-14, 2025

2nd International Conference on Drug Discovery and Development

Prague, Czech Republic
April 07-08, 2025

15th World Congress on Chemistry

Vancouver, Canada
May 14-15, 2025

17th International Conference on Clinical Chemistry

Toronto, Canada
June 26-27, 2025

14th World Congress on Chromatography

Paris, France

Evaluation of Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in